New Option OK'd for Pompe Disease FDA approves two-component therapy for patients not improving on enzyme replacement therapy Sep 29, 2023
Dianne Feinstein Dies; Prison for Alzheimer's Fraudsters; Kaiser Strike Looming Health news and commentary from around the Web gathered by 鶹ý staff Sep 29, 2023
FDA Relents, Approves Novel Antidepressant After Many Rejections Gepirone extended-release approved after nearly 2 decades of trying Sep 28, 2023
OSHA Comes in for Both Praise and Harsh Criticism at House Hearing Illinois lawmaker calls agency head "inept" during discussion of COVID vaccine mandate rule Sep 28, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Obamacare Makes Surprise Cameo in Second GOP Debate Fentanyl crisis, transgender care, and abortion also got some air time Sep 28, 2023
FDA Panel Overwhelmingly Rejects ALS Cell Therapy Echoing concerns from agency reviewers, advisors can't find evidence of efficacy Sep 28, 2023
With Shutdown Likely, Policy Experts Weigh Health Risks Food safety, innovation, and community health centers all could see trickle-down effects Sep 28, 2023
FDA Displeased With Companies Purposely Adding Sesame to More Foods Agency issues updated guidance for limiting cross-contamination in wake of FASTER act Sep 27, 2023
Mydriasis-Reversing Eye Drops Win FDA Approval Pupil diameter normalized significantly faster with phentolamine solution in phase III trials Sep 27, 2023
States Face Challenges With Medicaid and CHIP 'Redeterminations' CMS officials flag problem with states' auto-renewal systems Sep 27, 2023
Preventing Biden's Stumbles; Bruce Willis Aware of His Dementia? ABIM Prez to Retire Health news and commentary from around the Web gathered by 鶹ý staff Sep 27, 2023
FTC Sues Anesthesia Group and Its Private Equity Backers Companies accused of extracting "monopoly profits" while growing "monopoly power" Sep 26, 2023
COVID Drug and New Mutations; Costco Offers $29 Care; Trump Unmasked Over Bronzer Health news and commentary from around the Web gathered by 鶹ý staff Sep 26, 2023
FDA Staff Voice Serious Concerns About Investigational ALS Cell Therapy Data are "scientifically incomplete" and manufacturing info is "grossly deficient" Sep 25, 2023
Two Large Medical Groups Shun Medicare Advantage Plans San Diego doctor groups latest to withdraw, citing low pay, prior authorization problems Sep 25, 2023
White House Opens Gun Violence Prevention Office "We have to act, and we have to act now," says President Biden Sep 22, 2023
The White House Cancer Moonshot Is a Dud We're failing to take simple steps to reduce one of the biggest causes of cancer Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Flawed Rules in No Surprises Act Hurt Doctors and Patients, Experts Say Some practices are fighting to keep afloat, while patients are losing access to care Sep 21, 2023
Medicare Advantage Ads Should Look Different This Year KFF examines past predatory ads as new CMS regulation goes into effect Sep 21, 2023
FDA Advisors Grapple With Logistical, Ethical Issues of Artificial Womb Technology Further discussion about first-in-human trials is ongoing Sep 20, 2023
FDA Shoots Down Needle-Free EpiPen Alternative, Requests More Data Agency asks drugmaker for a repeat-dose study before approval Sep 20, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Large Study Eases Fears Over Zantac-Cancer Link In multinational cohort, cancer incidence with pulled drug no different than other H2RAs Sep 19, 2023
Want Better Health Outcomes? Check Out What Other Countries Do Countries who outperform the U.S. system have three things in common, expert says Sep 19, 2023
FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosis In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly Sep 18, 2023
Trump: 6-Week Abortion Ban a 'Mistake'; Capitol Doc Scrutiny; Immigrant Health Costs Health news and commentary from around the Web gathered by 鶹ý staff Sep 18, 2023
FDA Reviewers Have Concerns About Artificial Womb Trials in Humans The Pediatric Advisory Committee will discuss if data support a safe first-in-human trial Sep 15, 2023
No 'Silver Bullet' for Generic Drug Shortage, House Members Told A total of 301 drugs were in active shortage last year Sep 14, 2023
A 'SAD' Story: Patient Stuck With $176K Bill After Medicare Policy Switch CMS abruptly decided patients can self-administer Stelara -- even those with Parkinson's Sep 14, 2023
Drug Companies, Allies Fight Back on Medicare Drug Price Negotiations They argue that the government is using coercion while claiming sellers have options Sep 14, 2023
FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy Clinical meaningfulness is a different question, however Sep 13, 2023
What It Will Really Take to Restore Trust in the CDC A singular narrative, consistency, and relatability are paramount Sep 13, 2023
FDA Warns Companies About Unapproved Ophthalmic Products Walgreens and CVS among companies accused of marketing products with "heightened risk of harm" Sep 13, 2023
California Misinfo Law Is Destined for the Dustbin Amendment repeals language, but licensing boards apparently had authority all along Sep 13, 2023
DEA Gets an Earful About Telehealth Prescribing of Controlled Substances Proposed in-person visit requirements raises concern for psychiatry groups Sep 12, 2023
Novel System Snags FDA Approval for Severe Peripheral Arterial Disease Device designed to prevent amputation in chronic limb-threatening ischemia Sep 12, 2023
Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma Motixafortide plus filgrastim increased adequate harvest rate from 9.5% to 67.5% Sep 11, 2023
